Daniel Abdun-Nabi, President & COO at Emergent BioSolutions Inc. (EBS), sold 7,700 shares at $20.14 ($154K) on 2008-11-11, disclosed to the SEC on 2008-11-12.
Open-market sale of $154k EBS by President & COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 5,485 | $110K | 71.2% |
| 2 | $20.02 | 1,000 | $20K | 13.0% |
| 3 | $20.04 | 222 | $4K | 2.9% |
| 4 | $20.05 | 400 | $8K | 5.2% |
| 5 | $20.05 | 81 | $2K | 1.1% |
| 6 | $20.06 | 200 |
| $4K |
| 2.6% |
| 7 | $20.07 | 12 | $241 | 0.2% |
| 8 | $20.13 | 200 | $4K | 2.6% |
| 9 | $20.14 | 100 | $2K | 1.3% |
| Total | $20.01 avg | 7,700 | $154K | 100% |
| Filing → |
| EBS | SELL | 2018-09-18 | $1.9M | — | Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |